Policy Points
Molecular HIV surveillance and cluster detection and response (MHS/CDR) programs have been a core public health activity in the United States since 2018 and are the “fourth pillar” of the Ending the HIV Epidemic initiative launched in 2019.
MHS/CDR has caused controversy, including calls for a moratorium from networks of people living with HIV. In October 2022, the Presidential Advisory Council on HIV/AIDS (PACHA) adopted a resolution calling for major reforms.
We analyze the policy landscape and present four proposals to federal stakeholders pertaining to PACHA’s recommendations about incorporating opt-outs and plain-language notifications into MHS/CDR programs.